and Relevance Gene drive systems could solve ecological problems by altering entire populations of wild organisms. However, the self-sustaining nature of current CRISPR-based drive systems makes them likely to spread to most local populations, and very possibly to other populations of that species elsewhere in the world. Without a means of safe testing or securing international agreement prior to deployment, it is unclear how these types of gene drive systems can be ethically released. This proposal seeks to develop ?daisy drive? systems capable of precisely and economically altering local populations of wild organisms. Specifically, the project will develop ways of reducing the fitness cost of both alteration and suppression drive systems, precisely controlling the extent to which they will spread, and perfectly reversing genetic changes spread by other types of CRISPR-based drive systems. By providing a path to community-supported, diplomatically feasible, and economical deployment, this proposal will facilitate the prevention of numerous vector-borne and parasitic diseases by spreading disease resistance among vectors or directly suppressing populations of disease agents. We anticipate that daisy drive interventions will serve as powerful weapons suitable for combating malaria, schistosomiasis, dengue, Zika, Lyme disease, and many more.

Public Health Relevance

For ecological diseases such as malaria and Lyme, the number of infections depends on the number of mosquito carriers or wild animal reservoirs in the local environment. CRISPR-based gene drive systems could dramatically reduce disease by altering or suppressing these wild organisms, but the fact that they will spread indefinitely makes safe and ethical testing and deployment extremely difficult. This proposal will develop ?daisy drive? systems capable of precisely and efficiently alter local populations, thereby enabling individual communities to make their own public health decisions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
NIH Director’s New Innovator Awards (DP2)
Project #
3DP2AI136597-01S1
Application #
10085329
Study Section
Program Officer
Brown, Liliana L
Project Start
2017-09-01
Project End
2022-06-30
Budget Start
2020-09-23
Budget End
2022-06-30
Support Year
1
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Biology
Type
University-Wide
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Noble, Charleston; Adlam, Ben; Church, George M et al. (2018) Current CRISPR gene drive systems are likely to be highly invasive in wild populations. Elife 7:
Esvelt, Kevin M; Gemmell, Neil J (2017) Conservation demands safe gene drive. PLoS Biol 15:e2003850
Najjar, Devora A; Normandin, Avery M; Strait, Elizabeth A et al. (2017) Driving towards ecotechnologies. Pathog Glob Health 111:448-458